Anthony Phillips, CRNP

NPI: 1780134593
Total Payments
$11,464
2024 Payments
$2,658
Companies
31
Transactions
613
Medicare Patients
184
Medicare Billing
$31,627

Payment Breakdown by Category

Food & Beverage$11,358 (99.1%)
Education$99.99 (0.9%)
Travel$6.00 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $11,358 611 99.1%
Education $99.99 1 0.9%
Travel and Lodging $6.00 1 0.1%

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $1,911 79 $0 (2024)
ABBVIE INC. $1,260 107 $0 (2024)
Otsuka America Pharmaceutical, Inc. $996.12 48 $0 (2024)
ITI, Inc. $939.93 43 $0 (2023)
Vanda Pharmaceuticals Inc. $909.32 41 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $774.82 37 $0 (2024)
Alkermes, Inc. $747.65 45 $0 (2024)
Teva Pharmaceuticals USA, Inc. $644.84 39 $0 (2024)
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $453.94 23 $0 (2024)
Lundbeck LLC $446.31 22 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,658 147 Janssen Pharmaceuticals, Inc ($502.46)
2023 $3,387 163 Janssen Pharmaceuticals, Inc ($769.52)
2022 $3,036 158 Janssen Pharmaceuticals, Inc ($639.06)
2021 $2,383 145 AbbVie Inc. ($589.05)

All Payment Transactions

613 individual payment records from CMS Open Payments — Page 1 of 25

Date Company Product Nature Form Amount Type
12/23/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $23.19 General
Category: VILOXAZINE HYDROCHLORIDE
12/17/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $22.45 General
Category: CNS
12/16/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $20.71 General
Category: PSYCHIATRY
12/11/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $18.78 General
Category: PSYCHIATRY
12/09/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $6.42 General
Category: NEUROSCIENCE
12/06/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $30.85 General
Category: Neuroscience
12/04/2024 Teva Pharmaceuticals USA, Inc. UZEDY (Drug) Food and Beverage In-kind items and services $19.45 General
Category: Neurology
12/04/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $10.06 General
Category: NEUROSCIENCE
12/02/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $24.55 General
Category: Psychology/Psychiatric
11/22/2024 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $19.65 General
Category: Neuroscience
11/19/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $20.95 General
Category: CNS
11/18/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $20.72 General
Category: NEUROSCIENCE
11/18/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $7.75 General
Category: PSYCHIATRY
11/17/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $5.15 General
Category: PSYCHIATRY
11/14/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $16.15 General
Category: Psychiatry/Psychology
11/13/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $19.18 General
Category: PSYCHIATRY
11/12/2024 Almatica Pharma LLC LOREEV XR (Drug) Food and Beverage In-kind items and services $19.65 General
Category: ANTI-ANXIETY
11/08/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $15.27 General
Category: VILOXAZINE HYDROCHLORIDE
11/07/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $7.50 General
Category: NEUROSCIENCE
11/04/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $28.69 General
Category: Psychology/Psychiatric
11/04/2024 Tris Pharma Inc Dyanavel XR (Drug) Food and Beverage In-kind items and services $13.38 General
Category: ADHD
11/01/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $31.25 General
Category: Neuroscience
10/31/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $19.08 General
Category: Neuropsychiatry
10/29/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $19.52 General
Category: PSYCHIATRY
10/29/2024 Teva Pharmaceuticals USA, Inc. UZEDY (Drug) Food and Beverage In-kind items and services $8.39 General
Category: Neurology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 42 143 $20,785 $7,484
2022 2 48 199 $28,761 $10,607
2021 2 47 112 $14,450 $6,540
2020 2 47 139 $17,850 $6,995
Total Patients
184
Total Services
593
Medicare Billing
$31,627
Procedure Codes
8

All Medicare Procedures & Services

8 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 22 73 $13,505 $4,780 35.4%
90833 Psychotherapy with evaluation and management visit, 30 minutes Office 2023 20 70 $7,280 $2,704 37.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 26 109 $19,465 $7,083 36.4%
90833 Psychotherapy with evaluation and management visit, 30 minutes Office 2022 22 90 $9,296 $3,525 37.9%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 27 65 $9,750 $4,519 46.3%
90833 Psychotherapy performed with evaluation and management visit, 30 minutes Office 2021 20 47 $4,700 $2,021 43.0%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 24 79 $11,850 $4,562 38.5%
90833 Psychotherapy, 30 minutes Office 2020 23 60 $6,000 $2,433 40.6%

About Anthony Phillips, CRNP

Anthony Phillips, CRNP is a Psychiatric/Mental Health healthcare provider based in Helena, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2016. The National Provider Identifier (NPI) number assigned to this provider is 1780134593.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Anthony Phillips, CRNP has received a total of $11,464 in payments from pharmaceutical and medical device companies, with $2,658 received in 2024. These payments were reported across 613 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($11,358).

As a Medicare-enrolled provider, Phillips has provided services to 184 Medicare beneficiaries, totaling 593 services with total Medicare billing of $31,627. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.

Practice Information

  • Specialty Psychiatric/Mental Health
  • Location Helena, AL
  • Active Since 10/05/2016
  • Last Updated 10/05/2016
  • Taxonomy Code 363LP0808X
  • Entity Type Individual
  • NPI Number 1780134593

Products in Payments

  • CAPLYTA (Drug) $1,394
  • VRAYLAR (Drug) $1,260
  • SPRAVATO (Drug) $975.73
  • INVEGA SUSTENNA (Drug) $935.31
  • REXULTI (Drug) $783.70
  • TRINTELLIX (Drug) $774.82
  • HETLIOZ (Drug) $766.30
  • ARISTADA (Drug) $727.05
  • ABILIFY MAINTENA (Drug) $528.24
  • Auvelity (Drug) $437.66
  • INGREZZA (Drug) $362.71
  • AUSTEDO (Drug) $218.50
  • QELBREE (Drug) $204.61
  • Austedo XR (Drug) $166.59
  • UZEDY (Drug) $157.36
  • LOREEV XR (Drug) $151.82
  • Adzenys XR-ODT (Drug) $148.25
  • FANAPT (Drug) $143.02
  • Nuedexta (Drug) $135.71
  • LATUDA (Drug) $128.57

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatric/Mental Health Doctors in Helena